Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY1R | P25929 | 1/20 | 0.63 |
| ▸ | NPY2R | P49146 | 1/20 | 0.63 |
| ▸ | NPY4R | P50391 | 1/20 | 0.63 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.63 |
| ▸ | CXCR4 | P61073 | 4/20 | 0.60 |
| ▸ | MC4R | P32245 | 2/20 | 0.57 |
| ▸ | MC5R | P33032 | 2/20 | 0.57 |
| ▸ | MC3R | P41968 | 2/20 | 0.57 |
| ▸ | MC1R | Q01726 | 2/20 | 0.57 |
| ▸ | IL23R | Q5VWK5 | 2/20 | 0.57 |
| ▸ | GLP1R | P43220 | 8/20 | 0.57 |
| ▸ | CALCA | P06881 | 1/20 | 0.56 |
| ▸ | GNRHR | P30968 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30429251 | 0.87 | CALCA (0.62) | NPY1RNPY2RNPY4RNPY5RCXCR4 | |
| SCHEMBL29992945 | 0.85 | CALCA (0.59) | NPY1RNPY2RNPY4RNPY5RCXCR4 | |
| SCHEMBL30973980 | 0.85 | DPP3 (0.58) | CXCR4 | |
| SCHEMBL30974317 | 0.84 | DPP3 (0.58) | CXCR4 | |
| SCHEMBL31410847 | 0.84 | CXCR4 (0.66) | NPY1RNPY2RNPY4RNPY5RCXCR4 | |
| SCHEMBL29379403 | 0.83 | CCKBR (0.59) | MC4RMC5RMC3RMC1RIL23R | |
| SCHEMBL29496930 | 0.82 | NPY1R (0.62) | NPY1RNPY2RNPY4RNPY5RCXCR4 | |
| SCHEMBL22807694 | 0.82 | NPY1R (0.62) | NPY1RNPY2RNPY4RNPY5RCXCR4 | |
| SCHEMBL29461565 | 0.81 | IL23R (0.63) | NPY1RNPY2RNPY4RNPY5RCXCR4 | |
| SCHEMBL30256961 | 0.81 | CXCR4 (0.59) | NPY1RNPY2RNPY4RNPY5RCXCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4713094-A2 | PHARMACEUTICAL COMPOSITION AND METHOD FOR PREVENTION AND TREATMENT OF HEARING LOSS | Pharmazz, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| WO-2024238297-A2 | PHARMACEUTICAL COMPOSITION AND METHOD FOR PREVENTION AND TREATMENT OF HEARING LOSS | PHARMAZZ, INC. (US) | 2024-11-21 | — | — | WO | disclosed |
| US-20240382461-A1 | PHARMACEUTICAL COMPOSITION AND METHOD FOR PREVENTION AND TREATMENT OF HEARING LOSS | PHARMAZZ, INC. (US) | 2024-11-21 | — | — | US | disclosed |